AMZN
Amazon.com, Inc.
AMZN has the edge over INSE overall, supported by lower modeled downside and stronger valuation.
INSE
Inspired Entertainment, Inc.
INSE trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
INSE Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Stable | |
| Healthy | |
| Under pressure |
INSE's cash flow is currently healthy, and its profitability is stable, but its revenue and balance sheet are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN's PE is in its cheap range at 22x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 27x.
INSE PE Valuation
INSE has no meaningful PE right now: it lost money over the past year.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over INSE on the outlook, with more favorable earnings and revenue expectations.
INSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| Weakening | |
| Limited | |
| High |
Analysts expect INSE's earnings and revenue to decline, with profitability weakening.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over INSE on earnings quality, reporting a profit while its opponent remains loss making.
INSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.09 | — |
| Q3 2026 | -$0.25 | -113% |
| Q2 2026 | -$0.32 | -115% |
| Q1 2026 | -$0.60 | -125% |
| Q4 2025 | -$0.58 | -126% |
| Q3 2025 | $1.89 | +$1.90 |
| Q2 2025 | $2.08 | +$2.09 |
| Q1 2025 | $2.42 | +2100% |
| Q4 2024 | $2.22 | +754% |
INSE has swung to a loss: it lost $0.25 per share over the past year, after a profit the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over INSE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
INSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $61.4M | -29% |
| Q2 2026 | $60.8M | -24% |
| Q1 2026 | $57.2M | -5.3% |
| Q4 2025 | $77.2M | -4% |
| Q3 2025 | $86.2M | +11% |
| Q2 2025 | $80.3M | +6.2% |
| Q1 2025 | $60.4M | -4.3% |
| Q4 2024 | $80.4M | -1% |
INSE's revenue has slid since its 2023 peak: $61M last quarter, down 29% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +5.5 points |
| Q2 2026 | 16% | +6.4 points |
| Q1 2026 | 16% | +13 points |
| Q4 2025 | 15% | +1.2 points |
| Q3 2025 | 11% | -4 points |
| Q2 2025 | 9.8% | -2.6 points |
| Q1 2025 | 2.6% | +4.9 points |
| Q4 2024 | 13% | +2 points |
INSE has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
INSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $16.4M | +281% |
| Q2 2026 | $100K | -98% |
| Q1 2026 | $23M | +41% |
| Q4 2025 | -$9.9M | -719% |
| Q3 2025 | $4.3M | -81% |
| Q2 2025 | $5.6M | +$14.2M |
| Q1 2025 | $16.3M | +$17.1M |
| Q4 2024 | $1.6M | +$4.1M |
INSE has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
INSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2% | -595K shares |
| 1 year | -1.4% | -413K shares |
| 3 years | -1.5% | -423K shares |
| 5 years | +11% | +2.9M shares |
| Available history | +31% | +6.8M shares |
INSE has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2.6M |
| Q1 2026 | $2.6M |
| Q4 2023 | — |
| Q3 2023 | $1.5M |
| Q4 2022 | $400,000 |
| Q3 2022 | $4.9M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over INSE on leverage, with a lower net debt burden relative to earnings.
INSE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 3.7x | Elevated |
| Q3 2025 | 3.8x | Elevated |
| Q2 2025 | 3.8x | Elevated |
| Q1 2025 | 3.6x | Elevated |
| Q4 2024 | 3.8x | Elevated |
INSE's net debt is about 3.0 years of its operating earnings (EBITDA), down from 3.8 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
INSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 21.2 | Neutral |
INSE's weekly RSI is 40 (neutral) and its Stochastic is 21 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
INSE PE vs Consumer Cyclical Sector
| Metric | INSE | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
INSE has no meaningful PE right now: it lost money over the past year.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over INSE on trend strength, trading above more of its moving averages.
INSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.74 | 17% above |
| 20 week MA | $5.26 | 17% below |
| 50 week MA | $6.90 | 36% below |
| 100 week MA | $7.76 | 43% below |
| 200 week MA | $9.31 | 53% below |
INSE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 53% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over INSE on returns for 2026, with the stronger performance.
INSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.90 | $6.84 | -0.9% |
| 2021 | $6.84 | $12.2 | +78% |
| 2022 | $12.2 | $12.9 | +5.9% |
| 2023 | $12.9 | $9.88 | -23% |
| 2024 | $9.88 | $8.90 | -9.9% |
| 2025 | $8.90 | $9.51 | +6.9% |
| 2026 YTD | $9.51 | $4.39 | -54% |
INSE has finished lower in three of the last six years. It's down 54% so far in 2026.